Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for PITX1
Z-value: 2.50
Motif logo
Transcription factors associated with PITX1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PITX1
|
ENSG00000069011.11 | paired like homeodomain 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PITX1 | hg19_v2_chr5_-_134369973_134369988 | -0.04 | 8.2e-01 | Click! |
Activity profile of PITX1 motif
Sorted Z-values of PITX1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_+_161035655 | 10.09 |
ENST00000600454.1
|
AL591806.1
|
Uncharacterized protein |
| chr5_-_55224569 | 8.37 |
ENST00000595799.1
|
AC008914.1
|
Uncharacterized protein |
| chr12_-_66317967 | 8.08 |
ENST00000601398.1
|
AC090673.2
|
Uncharacterized protein |
| chr19_-_2256405 | 6.80 |
ENST00000300961.6
|
JSRP1
|
junctional sarcoplasmic reticulum protein 1 |
| chr22_-_24096562 | 6.72 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr22_-_24096630 | 6.60 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr11_-_118213455 | 6.49 |
ENST00000300692.4
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr7_+_73623717 | 6.05 |
ENST00000344995.5
ENST00000460943.1 |
LAT2
|
linker for activation of T cells family, member 2 |
| chr16_+_30386098 | 5.72 |
ENST00000322861.7
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr11_-_118213331 | 5.63 |
ENST00000392884.2
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr1_+_160765947 | 5.20 |
ENST00000263285.6
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
| chr7_+_142031986 | 5.08 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
| chrX_-_70326455 | 5.02 |
ENST00000374251.5
|
CXorf65
|
chromosome X open reading frame 65 |
| chr16_-_29757272 | 5.01 |
ENST00000329410.3
|
C16orf54
|
chromosome 16 open reading frame 54 |
| chr7_+_142334156 | 4.98 |
ENST00000390394.3
|
TRBV20-1
|
T cell receptor beta variable 20-1 |
| chr11_-_118213360 | 4.94 |
ENST00000529594.1
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex) |
| chr17_-_3599696 | 4.89 |
ENST00000225328.5
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
| chr1_-_179457805 | 4.88 |
ENST00000600581.1
|
AL160286.1
|
Uncharacterized protein |
| chr16_+_30484021 | 4.70 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr2_+_234104079 | 4.60 |
ENST00000417661.1
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr17_-_18950950 | 4.51 |
ENST00000284154.5
|
GRAP
|
GRB2-related adaptor protein |
| chr16_+_30483962 | 4.50 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr20_-_46041046 | 4.37 |
ENST00000437920.1
|
RP1-148H17.1
|
RP1-148H17.1 |
| chr14_+_22111077 | 4.37 |
ENST00000390423.2
|
TRAV1-2
|
T cell receptor alpha variable 1-2 |
| chr22_-_21360736 | 4.33 |
ENST00000547793.2
|
AC002472.1
|
Uncharacterized protein |
| chr19_-_54327542 | 4.32 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
| chr20_-_42355629 | 4.31 |
ENST00000373003.1
|
GTSF1L
|
gametocyte specific factor 1-like |
| chr1_+_180941695 | 4.30 |
ENST00000457152.2
|
AL162431.1
|
Uncharacterized protein |
| chr7_+_73624327 | 4.25 |
ENST00000361082.3
ENST00000275635.7 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family, member 2 |
| chr19_+_14693888 | 4.15 |
ENST00000547437.1
ENST00000397439.2 ENST00000417570.1 |
CLEC17A
|
C-type lectin domain family 17, member A |
| chr19_-_17932314 | 4.09 |
ENST00000598577.1
ENST00000317306.7 ENST00000379695.5 |
INSL3
|
insulin-like 3 (Leydig cell) |
| chr19_+_10751715 | 3.97 |
ENST00000430975.1
|
AC011475.1
|
Uncharacterized protein |
| chr16_-_68014732 | 3.97 |
ENST00000268793.4
|
DPEP3
|
dipeptidase 3 |
| chr17_+_26638667 | 3.94 |
ENST00000600595.1
|
AC061975.10
|
Uncharacterized protein |
| chr17_-_37934466 | 3.85 |
ENST00000583368.1
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr14_+_22089953 | 3.79 |
ENST00000542354.1
|
TRAV1-1
|
T cell receptor alpha variable 1-1 |
| chr17_-_3599492 | 3.70 |
ENST00000435558.1
ENST00000345901.3 |
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
| chr22_+_42095497 | 3.69 |
ENST00000401548.3
ENST00000540833.1 ENST00000400107.1 ENST00000300398.4 |
MEI1
|
meiosis inhibitor 1 |
| chr2_+_203104292 | 3.66 |
ENST00000594829.1
|
AC079354.2
|
Uncharacterized protein |
| chr1_-_24239844 | 3.61 |
ENST00000374472.4
|
CNR2
|
cannabinoid receptor 2 (macrophage) |
| chr16_-_30394143 | 3.61 |
ENST00000321367.3
ENST00000571393.1 |
SEPT1
|
septin 1 |
| chr16_-_12062333 | 3.59 |
ENST00000597717.1
|
AC007216.2
|
Uncharacterized protein |
| chr19_+_544034 | 3.58 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
| chr12_-_54691668 | 3.52 |
ENST00000553198.1
|
NFE2
|
nuclear factor, erythroid 2 |
| chr19_+_10959043 | 3.48 |
ENST00000397820.4
|
C19orf38
|
chromosome 19 open reading frame 38 |
| chr12_-_56756553 | 3.47 |
ENST00000398189.3
ENST00000541105.1 |
APOF
|
apolipoprotein F |
| chr7_-_97619508 | 3.47 |
ENST00000257627.4
|
OCM2
|
oncomodulin 2 |
| chrX_+_9431324 | 3.47 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
| chr3_-_195938256 | 3.41 |
ENST00000296326.3
|
ZDHHC19
|
zinc finger, DHHC-type containing 19 |
| chr19_-_2085323 | 3.38 |
ENST00000591638.1
|
MOB3A
|
MOB kinase activator 3A |
| chr2_+_204571198 | 3.37 |
ENST00000374481.3
ENST00000458610.2 ENST00000324106.8 |
CD28
|
CD28 molecule |
| chr16_+_28943260 | 3.37 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
| chr12_-_7899958 | 3.37 |
ENST00000360345.3
|
CLEC4C
|
C-type lectin domain family 4, member C |
| chr12_-_7902069 | 3.33 |
ENST00000542353.1
ENST00000540085.1 |
CLEC4C
|
C-type lectin domain family 4, member C |
| chr16_+_28874345 | 3.31 |
ENST00000566209.1
|
SH2B1
|
SH2B adaptor protein 1 |
| chr1_+_158815588 | 3.26 |
ENST00000438394.1
|
MNDA
|
myeloid cell nuclear differentiation antigen |
| chr1_-_36937075 | 3.26 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
| chr12_-_57644952 | 3.26 |
ENST00000554578.1
ENST00000546246.2 ENST00000553489.1 ENST00000332782.2 |
STAC3
|
SH3 and cysteine rich domain 3 |
| chr16_-_30393752 | 3.25 |
ENST00000566517.1
ENST00000605106.1 |
SEPT1
SEPT1
|
septin 1 Uncharacterized protein |
| chr1_-_150693318 | 3.22 |
ENST00000442853.1
ENST00000368995.4 ENST00000368993.2 ENST00000361824.2 ENST00000322343.7 |
HORMAD1
|
HORMA domain containing 1 |
| chr4_-_39033963 | 3.21 |
ENST00000381938.3
|
TMEM156
|
transmembrane protein 156 |
| chr17_+_4835580 | 3.17 |
ENST00000329125.5
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide |
| chr14_+_22591276 | 3.12 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
| chr16_+_12058961 | 3.12 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
| chr12_-_6756559 | 3.11 |
ENST00000536350.1
ENST00000414226.2 ENST00000546114.1 |
ACRBP
|
acrosin binding protein |
| chr16_-_68034470 | 3.11 |
ENST00000412757.2
|
DPEP2
|
dipeptidase 2 |
| chr19_+_17865011 | 3.10 |
ENST00000596462.1
ENST00000596865.1 ENST00000598960.1 ENST00000539407.1 |
FCHO1
|
FCH domain only 1 |
| chr7_+_141695671 | 3.10 |
ENST00000497673.1
ENST00000475668.2 |
MGAM
|
maltase-glucoamylase (alpha-glucosidase) |
| chr17_+_47448102 | 3.08 |
ENST00000576461.1
|
RP11-81K2.1
|
Uncharacterized protein |
| chr11_+_65647280 | 3.02 |
ENST00000307886.3
ENST00000528419.1 ENST00000526034.1 |
CTSW
|
cathepsin W |
| chr22_+_18260077 | 3.01 |
ENST00000600723.1
|
LINC00528
|
long intergenic non-protein coding RNA 528 |
| chr16_+_30194118 | 2.99 |
ENST00000563778.1
|
CORO1A
|
coronin, actin binding protein, 1A |
| chr1_-_186365908 | 2.99 |
ENST00000598663.1
|
AL596220.1
|
Uncharacterized protein |
| chr19_+_41092680 | 2.98 |
ENST00000594298.1
ENST00000597396.1 |
SHKBP1
|
SH3KBP1 binding protein 1 |
| chr17_+_7338737 | 2.97 |
ENST00000323206.1
ENST00000396568.1 |
TMEM102
|
transmembrane protein 102 |
| chr1_-_9714644 | 2.96 |
ENST00000377320.3
|
C1orf200
|
chromosome 1 open reading frame 200 |
| chr19_+_42824511 | 2.94 |
ENST00000601644.1
|
TMEM145
|
transmembrane protein 145 |
| chr14_+_76072096 | 2.91 |
ENST00000555058.1
|
FLVCR2
|
feline leukemia virus subgroup C cellular receptor family, member 2 |
| chr2_-_198062758 | 2.91 |
ENST00000328737.2
|
ANKRD44
|
ankyrin repeat domain 44 |
| chr19_+_999601 | 2.89 |
ENST00000594393.1
|
AC004528.1
|
Uncharacterized protein |
| chr7_+_141695633 | 2.89 |
ENST00000549489.2
|
MGAM
|
maltase-glucoamylase (alpha-glucosidase) |
| chr7_+_5920429 | 2.88 |
ENST00000242104.5
|
OCM
|
oncomodulin |
| chr16_+_67678818 | 2.85 |
ENST00000334583.6
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
| chr5_-_157161727 | 2.84 |
ENST00000599823.1
|
AC026407.1
|
Uncharacterized protein |
| chr12_+_42624050 | 2.82 |
ENST00000601185.1
|
AC020629.1
|
Uncharacterized protein |
| chr2_+_208527094 | 2.81 |
ENST00000429730.1
|
AC079767.4
|
AC079767.4 |
| chr1_+_247582097 | 2.80 |
ENST00000391827.2
|
NLRP3
|
NLR family, pyrin domain containing 3 |
| chr16_+_30387141 | 2.78 |
ENST00000566955.1
|
MYLPF
|
myosin light chain, phosphorylatable, fast skeletal muscle |
| chr19_-_2096259 | 2.77 |
ENST00000588048.1
ENST00000357066.3 |
MOB3A
|
MOB kinase activator 3A |
| chr9_+_131445703 | 2.76 |
ENST00000454747.1
|
SET
|
SET nuclear oncogene |
| chr3_+_186739636 | 2.73 |
ENST00000440338.1
ENST00000448044.1 |
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
| chr1_+_207070775 | 2.68 |
ENST00000391929.3
ENST00000294984.2 ENST00000367093.3 |
IL24
|
interleukin 24 |
| chr5_+_54320078 | 2.67 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
| chr1_-_153348067 | 2.64 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
| chr16_+_68071816 | 2.64 |
ENST00000562246.1
|
DUS2
|
dihydrouridine synthase 2 |
| chr6_+_35704855 | 2.63 |
ENST00000288065.2
ENST00000373866.3 |
ARMC12
|
armadillo repeat containing 12 |
| chr19_+_1077393 | 2.61 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
| chr17_+_7254184 | 2.61 |
ENST00000575415.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr1_+_160765919 | 2.61 |
ENST00000341032.4
ENST00000368041.2 ENST00000368040.1 |
LY9
|
lymphocyte antigen 9 |
| chr14_+_22204418 | 2.58 |
ENST00000390426.2
|
TRAV4
|
T cell receptor alpha variable 4 |
| chr20_+_361261 | 2.58 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
| chr10_-_125853200 | 2.57 |
ENST00000421115.1
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
| chr19_+_55014085 | 2.55 |
ENST00000351841.2
|
LAIR2
|
leukocyte-associated immunoglobulin-like receptor 2 |
| chr19_-_48547294 | 2.54 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
| chr7_+_73624276 | 2.52 |
ENST00000475494.1
ENST00000398475.1 |
LAT2
|
linker for activation of T cells family, member 2 |
| chr16_+_30087288 | 2.51 |
ENST00000279387.7
ENST00000562664.1 ENST00000562222.1 |
PPP4C
|
protein phosphatase 4, catalytic subunit |
| chr1_-_109203685 | 2.50 |
ENST00000402983.1
ENST00000420055.1 |
HENMT1
|
HEN1 methyltransferase homolog 1 (Arabidopsis) |
| chr22_+_24819565 | 2.49 |
ENST00000424232.1
ENST00000486108.1 |
ADORA2A
|
adenosine A2a receptor |
| chr14_-_65785502 | 2.48 |
ENST00000553754.1
|
CTD-2509G16.5
|
CTD-2509G16.5 |
| chr19_+_47840346 | 2.47 |
ENST00000600626.1
|
C5AR2
|
complement component 5a receptor 2 |
| chrX_-_70838306 | 2.45 |
ENST00000373691.4
ENST00000373693.3 |
CXCR3
|
chemokine (C-X-C motif) receptor 3 |
| chr1_+_160765884 | 2.44 |
ENST00000392203.4
|
LY9
|
lymphocyte antigen 9 |
| chr16_-_69390209 | 2.42 |
ENST00000563634.1
|
RP11-343C2.9
|
Uncharacterized protein |
| chr16_-_68033356 | 2.41 |
ENST00000393847.1
ENST00000573808.1 ENST00000572624.1 |
DPEP2
|
dipeptidase 2 |
| chr12_+_123259063 | 2.39 |
ENST00000392441.4
ENST00000539171.1 |
CCDC62
|
coiled-coil domain containing 62 |
| chr20_+_55099542 | 2.38 |
ENST00000371328.3
|
FAM209A
|
family with sequence similarity 209, member A |
| chr12_-_53601055 | 2.38 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
| chr1_-_160832642 | 2.37 |
ENST00000368034.4
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
| chr9_-_72435576 | 2.36 |
ENST00000453410.1
ENST00000526458.1 ENST00000439418.1 |
C9orf135-AS1
|
C9orf135 antisense RNA 1 (head to head) |
| chr3_+_39371255 | 2.34 |
ENST00000414803.1
ENST00000545843.1 |
CCR8
|
chemokine (C-C motif) receptor 8 |
| chr12_+_54892550 | 2.34 |
ENST00000545638.2
|
NCKAP1L
|
NCK-associated protein 1-like |
| chr17_-_3595181 | 2.34 |
ENST00000552050.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
| chr12_-_7904201 | 2.34 |
ENST00000354629.5
|
CLEC4C
|
C-type lectin domain family 4, member C |
| chr4_-_6692246 | 2.34 |
ENST00000499502.2
|
RP11-539L10.2
|
RP11-539L10.2 |
| chr8_-_27941359 | 2.33 |
ENST00000418860.1
|
NUGGC
|
nuclear GTPase, germinal center associated |
| chr14_+_22931924 | 2.33 |
ENST00000390477.2
|
TRDC
|
T cell receptor delta constant |
| chr10_+_96443204 | 2.32 |
ENST00000339022.5
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18 |
| chr5_+_54398463 | 2.32 |
ENST00000274306.6
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
| chr16_+_12059050 | 2.31 |
ENST00000396495.3
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
| chr12_+_2912363 | 2.29 |
ENST00000544366.1
|
FKBP4
|
FK506 binding protein 4, 59kDa |
| chr7_-_99381798 | 2.29 |
ENST00000415003.1
ENST00000354593.2 |
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4 |
| chr19_-_14889349 | 2.28 |
ENST00000315576.3
ENST00000392967.2 ENST00000346057.1 ENST00000353876.1 ENST00000353005.1 |
EMR2
|
egf-like module containing, mucin-like, hormone receptor-like 2 |
| chr6_-_128239685 | 2.28 |
ENST00000368250.1
|
THEMIS
|
thymocyte selection associated |
| chr5_+_76145920 | 2.28 |
ENST00000317593.4
|
S100Z
|
S100 calcium binding protein Z |
| chrX_-_70329118 | 2.27 |
ENST00000374188.3
|
IL2RG
|
interleukin 2 receptor, gamma |
| chr1_+_160765860 | 2.27 |
ENST00000368037.5
|
LY9
|
lymphocyte antigen 9 |
| chr16_+_72042487 | 2.25 |
ENST00000572887.1
ENST00000219240.4 ENST00000574309.1 ENST00000576145.1 |
DHODH
|
dihydroorotate dehydrogenase (quinone) |
| chr17_-_3599327 | 2.25 |
ENST00000551178.1
ENST00000552276.1 ENST00000547178.1 |
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
| chr12_+_53774423 | 2.24 |
ENST00000426431.2
|
SP1
|
Sp1 transcription factor |
| chr19_+_14491948 | 2.23 |
ENST00000358600.3
|
CD97
|
CD97 molecule |
| chr6_+_35704804 | 2.22 |
ENST00000373869.3
|
ARMC12
|
armadillo repeat containing 12 |
| chr19_-_8642289 | 2.21 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
| chr6_-_31763721 | 2.20 |
ENST00000375663.3
|
VARS
|
valyl-tRNA synthetase |
| chr13_+_50202435 | 2.20 |
ENST00000282026.1
|
ARL11
|
ADP-ribosylation factor-like 11 |
| chr7_+_76107444 | 2.20 |
ENST00000435861.1
|
DTX2
|
deltex homolog 2 (Drosophila) |
| chr17_+_7982800 | 2.19 |
ENST00000399413.3
|
AC129492.6
|
AC129492.6 |
| chr19_-_54850417 | 2.19 |
ENST00000291759.4
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 |
| chr17_-_5321549 | 2.19 |
ENST00000572809.1
|
NUP88
|
nucleoporin 88kDa |
| chr3_+_172034218 | 2.19 |
ENST00000366261.2
|
AC092964.1
|
Uncharacterized protein |
| chr9_-_117160738 | 2.19 |
ENST00000448674.1
|
RP11-9M16.2
|
RP11-9M16.2 |
| chr17_-_34524157 | 2.18 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
| chr17_-_42994283 | 2.17 |
ENST00000593179.1
|
GFAP
|
glial fibrillary acidic protein |
| chr9_-_139927462 | 2.17 |
ENST00000314412.6
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
| chr12_+_56324756 | 2.17 |
ENST00000331886.5
ENST00000555090.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
| chr8_-_126963387 | 2.17 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
| chr19_+_16254488 | 2.17 |
ENST00000588246.1
ENST00000593031.1 |
HSH2D
|
hematopoietic SH2 domain containing |
| chr1_-_150738261 | 2.16 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
| chr7_+_142423143 | 2.16 |
ENST00000390399.3
|
TRBV27
|
T cell receptor beta variable 27 |
| chr12_-_51718436 | 2.13 |
ENST00000544402.1
|
BIN2
|
bridging integrator 2 |
| chr7_-_75005425 | 2.13 |
ENST00000594196.1
|
AC006014.1
|
Uncharacterized protein |
| chr19_+_24009879 | 2.12 |
ENST00000354585.4
|
RPSAP58
|
ribosomal protein SA pseudogene 58 |
| chr15_-_90358564 | 2.12 |
ENST00000559874.1
|
ANPEP
|
alanyl (membrane) aminopeptidase |
| chr9_-_71161505 | 2.09 |
ENST00000446290.1
|
RP11-274B18.2
|
RP11-274B18.2 |
| chr22_-_37571089 | 2.08 |
ENST00000453962.1
ENST00000429622.1 ENST00000445595.1 |
IL2RB
|
interleukin 2 receptor, beta |
| chr19_+_46003056 | 2.07 |
ENST00000401593.1
ENST00000396736.2 |
PPM1N
|
protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) |
| chr17_+_8869157 | 2.06 |
ENST00000585297.1
|
CTB-41I6.1
|
CTB-41I6.1 |
| chr14_+_22964877 | 2.06 |
ENST00000390494.1
|
TRAJ43
|
T cell receptor alpha joining 43 |
| chr17_-_3595042 | 2.05 |
ENST00000552723.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
| chr12_+_32115400 | 2.04 |
ENST00000381054.3
|
KIAA1551
|
KIAA1551 |
| chr4_-_38784572 | 2.03 |
ENST00000308973.4
ENST00000361424.2 |
TLR10
|
toll-like receptor 10 |
| chr12_-_127256858 | 2.03 |
ENST00000542248.1
ENST00000540684.1 |
LINC00944
|
long intergenic non-protein coding RNA 944 |
| chr12_-_6677422 | 2.02 |
ENST00000382421.3
ENST00000545200.1 ENST00000399466.2 ENST00000536124.1 ENST00000540228.1 ENST00000542867.1 ENST00000545492.1 ENST00000322166.5 ENST00000545915.1 |
NOP2
|
NOP2 nucleolar protein |
| chr19_-_18197799 | 2.01 |
ENST00000430026.3
ENST00000593993.2 |
IL12RB1
|
interleukin 12 receptor, beta 1 |
| chr1_-_100231349 | 2.01 |
ENST00000287474.5
ENST00000414213.1 |
FRRS1
|
ferric-chelate reductase 1 |
| chr14_-_23292596 | 2.01 |
ENST00000554741.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr19_+_52264449 | 2.00 |
ENST00000599326.1
ENST00000598953.1 |
FPR2
|
formyl peptide receptor 2 |
| chr12_-_7899935 | 1.99 |
ENST00000543765.1
|
CLEC4C
|
C-type lectin domain family 4, member C |
| chr7_+_102196256 | 1.99 |
ENST00000341656.4
|
SPDYE2
|
speedy/RINGO cell cycle regulator family member E2 |
| chr7_+_102292796 | 1.99 |
ENST00000436228.2
|
SPDYE2B
|
speedy/RINGO cell cycle regulator family member E2B |
| chr7_+_98971863 | 1.98 |
ENST00000443222.1
ENST00000414376.1 |
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
| chr17_+_7239821 | 1.98 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
| chr12_+_147052 | 1.98 |
ENST00000594563.1
|
AC026369.1
|
Uncharacterized protein |
| chr19_-_58204128 | 1.97 |
ENST00000597520.1
|
AC004017.1
|
Uncharacterized protein |
| chr1_-_156269428 | 1.97 |
ENST00000339922.3
|
VHLL
|
von Hippel-Lindau tumor suppressor-like |
| chr3_-_52029958 | 1.97 |
ENST00000294189.6
|
RPL29
|
ribosomal protein L29 |
| chr15_-_38852251 | 1.96 |
ENST00000558432.1
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
| chr1_-_160832670 | 1.96 |
ENST00000368032.2
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
| chr22_-_37976082 | 1.96 |
ENST00000215886.4
|
LGALS2
|
lectin, galactoside-binding, soluble, 2 |
| chr16_+_30484054 | 1.96 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
| chr22_-_21984282 | 1.95 |
ENST00000398873.3
ENST00000292778.6 |
YDJC
|
YdjC homolog (bacterial) |
| chr19_-_4302375 | 1.94 |
ENST00000600114.1
ENST00000600349.1 ENST00000595645.1 ENST00000301272.2 |
TMIGD2
|
transmembrane and immunoglobulin domain containing 2 |
| chr1_-_109203648 | 1.94 |
ENST00000370031.1
|
HENMT1
|
HEN1 methyltransferase homolog 1 (Arabidopsis) |
| chr1_-_739137 | 1.94 |
ENST00000599533.1
|
AL669831.1
|
Uncharacterized protein |
| chr4_+_40201954 | 1.94 |
ENST00000511121.1
|
RHOH
|
ras homolog family member H |
| chr3_+_48264816 | 1.94 |
ENST00000296435.2
ENST00000576243.1 |
CAMP
|
cathelicidin antimicrobial peptide |
| chr14_-_23285069 | 1.93 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr8_-_102275131 | 1.93 |
ENST00000523121.1
|
KB-1410C5.2
|
KB-1410C5.2 |
| chr17_-_34625719 | 1.92 |
ENST00000422211.2
ENST00000542124.1 |
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1 |
| chr5_-_140013275 | 1.92 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
| chr1_-_224216371 | 1.91 |
ENST00000600307.1
|
AC138393.1
|
Uncharacterized protein |
Network of associatons between targets according to the STRING database.
First level regulatory network of PITX1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 2.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 1.4 | 4.1 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
| 1.1 | 4.3 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 1.1 | 17.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 1.1 | 3.2 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 1.0 | 5.1 | GO:0032796 | uropod organization(GO:0032796) |
| 1.0 | 2.9 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 1.0 | 3.9 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 1.0 | 4.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.9 | 6.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.9 | 4.3 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.8 | 4.9 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.8 | 2.3 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
| 0.7 | 2.2 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.7 | 4.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.7 | 2.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.6 | 16.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.6 | 1.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.6 | 10.6 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.6 | 11.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.6 | 1.7 | GO:1904303 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.6 | 1.7 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 0.6 | 1.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.6 | 3.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.6 | 1.7 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.5 | 1.6 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) positive regulation of mast cell cytokine production(GO:0032765) mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.5 | 4.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.5 | 3.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 | 3.6 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.5 | 5.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 2.0 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.5 | 2.0 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.5 | 2.5 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.5 | 4.8 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.5 | 2.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.5 | 1.4 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.5 | 1.4 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.5 | 0.9 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.5 | 0.5 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.4 | 1.8 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.4 | 1.3 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.4 | 17.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.4 | 4.7 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.4 | 1.2 | GO:0070781 | response to biotin(GO:0070781) |
| 0.4 | 1.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.4 | 1.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.4 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 4.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.4 | 1.9 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.4 | 1.1 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.4 | 1.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.4 | 1.5 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
| 0.4 | 1.1 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.4 | 1.5 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.4 | 1.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.4 | 2.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.4 | 1.1 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.3 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.3 | 1.7 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.3 | 1.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.3 | 1.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 | 1.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 0.3 | 1.3 | GO:0060032 | notochord regression(GO:0060032) |
| 0.3 | 2.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.3 | 1.6 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.3 | 1.3 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.3 | 2.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.3 | 2.5 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.3 | 3.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 | 0.9 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
| 0.3 | 2.2 | GO:0097319 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.3 | 1.8 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.3 | 1.2 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 2.1 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.3 | 0.9 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.3 | 1.8 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.3 | 0.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.3 | 4.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.3 | 0.3 | GO:0039519 | modulation by virus of host autophagy(GO:0039519) |
| 0.3 | 3.1 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 0.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.3 | 2.0 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.3 | 1.1 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.3 | 2.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.3 | 1.1 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.3 | 1.1 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.3 | 2.4 | GO:1901660 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.3 | 1.3 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.3 | 0.8 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.3 | 0.5 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 1.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.3 | 0.8 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.3 | 2.3 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.3 | 9.1 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.3 | 1.0 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
| 0.3 | 3.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 0.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.2 | 0.5 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.2 | 0.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.2 | 0.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.2 | 1.9 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 1.9 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.2 | 1.6 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.2 | 3.0 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 | 5.9 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.2 | 1.3 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.2 | 2.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.2 | 1.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.2 | 1.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 1.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 2.8 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.2 | 2.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 | 2.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.2 | 2.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 0.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 | 4.2 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.2 | 21.2 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.2 | 0.6 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.2 | 0.8 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.2 | 0.4 | GO:1990619 | histone H3-K9 deacetylation(GO:1990619) |
| 0.2 | 0.6 | GO:0006433 | glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
| 0.2 | 0.6 | GO:0035570 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 1.6 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 | 2.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.2 | 1.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 | 5.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 2.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.2 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.2 | 0.6 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.2 | 1.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 | 1.0 | GO:0010157 | response to chlorate(GO:0010157) |
| 0.2 | 1.1 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 0.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.2 | 0.6 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.2 | 2.2 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.7 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.2 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 0.5 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 | 0.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.2 | 0.9 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 1.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 1.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 0.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.2 | 1.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 | 1.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.2 | 1.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.2 | 3.0 | GO:0015886 | heme transport(GO:0015886) |
| 0.2 | 4.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 | 1.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 1.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.2 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 | 0.5 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 | 1.9 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.2 | 1.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.2 | 1.4 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.2 | 0.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.2 | 1.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.2 | 0.6 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 0.9 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.2 | 0.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.2 | 2.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 | 0.6 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.2 | 1.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 | 0.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 | 1.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 1.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 2.5 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.1 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.1 | 0.4 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.1 | 1.6 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 1.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 1.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.1 | 0.6 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 | 1.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.4 | GO:0097187 | dentinogenesis(GO:0097187) regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 1.0 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 | 0.7 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.1 | 0.8 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 | 1.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 4.7 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 3.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 1.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.1 | 0.9 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.1 | 2.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.1 | 1.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 | 1.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.3 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 0.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.5 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.1 | 1.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 | 2.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.5 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.1 | 0.6 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 | 2.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 | 1.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 1.0 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 | 0.9 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.1 | 1.6 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.4 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 0.1 | 0.8 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.1 | GO:0071352 | cellular response to interleukin-2(GO:0071352) |
| 0.1 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.2 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
| 0.1 | 1.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 | 0.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.4 | GO:1902356 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.1 | 0.9 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 3.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 | 2.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 0.9 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.1 | 1.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 | 0.5 | GO:1903516 | regulation of single strand break repair(GO:1903516) |
| 0.1 | 5.4 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.1 | 0.5 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 | 0.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 6.3 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.1 | 1.1 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.1 | 0.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 | 1.4 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.1 | 2.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 | 1.4 | GO:0046324 | regulation of glucose transport(GO:0010827) regulation of glucose import(GO:0046324) |
| 0.1 | 1.8 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.1 | 3.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 2.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 0.9 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 | 1.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 1.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.1 | 1.9 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 1.0 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 0.4 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.1 | 2.2 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.4 | GO:1900111 | regulation of histone H3-K9 dimethylation(GO:1900109) positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.1 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.1 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.1 | 0.2 | GO:0072641 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.1 | 1.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.3 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.1 | 1.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.1 | 15.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 | 0.3 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.1 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 1.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.7 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 1.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 | 1.8 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
| 0.1 | 1.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 | 3.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 1.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 17.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 2.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 | 1.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 | 1.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.1 | 3.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 1.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 5.6 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 3.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 2.2 | GO:0051197 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.1 | 0.7 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
| 0.1 | 0.5 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.1 | 0.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 2.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 1.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 2.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 0.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 0.4 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 | 0.4 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.1 | 3.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 | 0.7 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.1 | 1.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.4 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 3.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.6 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 0.1 | 1.7 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
| 0.1 | 4.3 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 1.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 2.8 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.1 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 3.9 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 | 0.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 0.1 | 0.2 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
| 0.1 | 0.4 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.1 | 0.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.1 | 2.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 1.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.1 | 0.9 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.7 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.3 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
| 0.1 | 1.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 | 2.7 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 1.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 1.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.1 | 2.6 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.1 | 1.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 | 0.2 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 | 0.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.1 | 5.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 0.3 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.1 | 0.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.9 | GO:0034349 | positive regulation of mitochondrial membrane potential(GO:0010918) glial cell apoptotic process(GO:0034349) |
| 0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.1 | 1.6 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.4 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.1 | 5.7 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 | 1.5 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.4 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 1.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
| 0.1 | 0.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.1 | 0.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.1 | 0.5 | GO:1903772 | virus maturation(GO:0019075) regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 | 1.4 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.1 | 0.5 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 | 1.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 | 1.0 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.1 | 1.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 3.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 | 0.3 | GO:0007584 | response to nutrient(GO:0007584) |
| 0.1 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.7 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.1 | 0.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 0.4 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.1 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.1 | 2.8 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.1 | 1.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 0.2 | GO:1904585 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
| 0.1 | 0.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 3.7 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
| 0.1 | 1.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 | 2.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 | 0.9 | GO:0001553 | luteinization(GO:0001553) |
| 0.1 | 1.8 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.1 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.1 | 6.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.1 | 0.3 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 0.1 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.1 | 1.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.1 | 0.7 | GO:0048066 | developmental pigmentation(GO:0048066) |
| 0.1 | 1.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.1 | 1.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 0.1 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 0.7 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.3 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 0.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 2.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.1 | 0.3 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 | 2.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 0.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.1 | 0.4 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 | 1.2 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 | 0.2 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.1 | 0.9 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.0 | 0.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.0 | 1.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.0 | 0.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.0 | 0.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 1.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.0 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.0 | 0.9 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.0 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
| 0.0 | 0.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.0 | 0.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 | 2.4 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
| 0.0 | 0.9 | GO:0009651 | response to salt stress(GO:0009651) |
| 0.0 | 1.0 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.2 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 | 0.6 | GO:0044344 | cellular response to fibroblast growth factor stimulus(GO:0044344) |
| 0.0 | 1.9 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.0 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 | 0.6 | GO:0032094 | response to food(GO:0032094) |
| 0.0 | 0.3 | GO:0044550 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) |
| 0.0 | 2.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.0 | 0.6 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.0 | 3.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.9 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 4.5 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.0 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 0.3 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.0 | 0.7 | GO:0046782 | regulation of viral transcription(GO:0046782) |
| 0.0 | 0.9 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
| 0.0 | 1.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.4 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.0 | 0.8 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.0 | 0.4 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.0 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
| 0.0 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.0 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.0 | 0.6 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.0 | 1.2 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
| 0.0 | 1.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 | 1.2 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 1.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.3 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.0 | 1.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 1.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 2.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 | 0.3 | GO:0043092 | L-amino acid import(GO:0043092) |
| 0.0 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.0 | 0.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 2.4 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
| 0.0 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.0 | 0.2 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.0 | 0.5 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 | 0.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.0 | 1.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 | 3.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
| 0.0 | 0.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.0 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 4.8 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.0 | 0.5 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.0 | 2.8 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.0 | 0.1 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.0 | 0.2 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.0 | 0.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.0 | 1.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
| 0.0 | 3.5 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.0 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 1.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 | 0.5 | GO:0009314 | response to radiation(GO:0009314) |
| 0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.0 | 0.3 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.0 | 1.8 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.0 | 2.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.0 | 1.1 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.6 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.0 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.0 | 0.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 0.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.5 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.7 | GO:0035909 | aorta morphogenesis(GO:0035909) |
| 0.0 | 0.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.0 | 2.2 | GO:0045859 | regulation of protein kinase activity(GO:0045859) |
| 0.0 | 0.2 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 | 0.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.0 | 0.2 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 0.6 | GO:0061641 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 0.8 | GO:0008344 | adult locomotory behavior(GO:0008344) |
| 0.0 | 0.2 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.0 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.9 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.0 | 0.6 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.1 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 | 0.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.6 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.4 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 | 1.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.0 | 0.7 | GO:0016573 | histone acetylation(GO:0016573) |
| 0.0 | 1.7 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 | 1.7 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 | 0.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.0 | 0.1 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.0 | 0.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 3.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
| 0.0 | 0.8 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.9 | GO:0042107 | cytokine biosynthetic process(GO:0042089) cytokine metabolic process(GO:0042107) |
| 0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.7 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
| 0.0 | 3.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.0 | 0.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.0 | 0.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 | 0.0 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.0 | 0.1 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 | 0.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.3 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.0 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 | 0.2 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.0 | 0.4 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.0 | 0.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.0 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
| 0.0 | 4.9 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 | 0.1 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 | 0.8 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.0 | 0.2 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.0 | 0.2 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 | 0.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 | 0.3 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 1.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.0 | 0.2 | GO:0071174 | negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) |
| 0.0 | 0.4 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 | 0.0 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 | 0.3 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
| 0.0 | 1.0 | GO:0007286 | spermatid development(GO:0007286) |
| 0.0 | 0.3 | GO:0048599 | oocyte development(GO:0048599) |
| 0.0 | 0.8 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 18.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.1 | 12.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.7 | 2.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.6 | 5.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.6 | 0.6 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.5 | 1.6 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.5 | 15.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.5 | 2.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.5 | 2.0 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.5 | 2.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.4 | 4.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.4 | 2.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.4 | 16.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.3 | 2.7 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 1.6 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.3 | 1.2 | GO:0000811 | GINS complex(GO:0000811) |
| 0.3 | 2.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 3.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.2 | 27.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.2 | 15.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 1.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.2 | 5.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 0.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.2 | 4.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 2.8 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.2 | 2.8 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.2 | 1.6 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.2 | 1.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 1.0 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.2 | 1.0 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.2 | 1.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.2 | 1.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 8.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.2 | 0.7 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.2 | 2.4 | GO:0000243 | commitment complex(GO:0000243) |
| 0.2 | 5.4 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.2 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
| 0.2 | 2.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.9 | GO:0032021 | NELF complex(GO:0032021) |
| 0.1 | 0.4 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.1 | 0.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 1.3 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.1 | 1.0 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.1 | 0.4 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.1 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 0.9 | GO:0042825 | TAP complex(GO:0042825) |
| 0.1 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 0.4 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.1 | 1.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 1.8 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 2.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 1.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.1 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.1 | 10.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 3.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.1 | 0.3 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.1 | 0.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.1 | 1.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.1 | 1.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 1.3 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.1 | 3.9 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 1.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 5.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 0.4 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.1 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.7 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 2.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 1.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 1.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 10.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.5 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 1.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.1 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 6.6 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 0.9 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.1 | 0.7 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 6.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 2.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.9 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
| 0.1 | 0.5 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 0.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.1 | 0.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.1 | 3.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
| 0.1 | 2.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.7 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 0.4 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.1 | 3.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.1 | 1.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 2.3 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 1.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 0.9 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 1.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 3.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 1.0 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.1 | 3.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.1 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.1 | 1.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 3.5 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.1 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.9 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.1 | 3.0 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.1 | 18.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 1.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.0 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 0.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 2.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.0 | 1.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 1.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.0 | 0.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.0 | 0.6 | GO:0044454 | nuclear chromosome part(GO:0044454) |
| 0.0 | 0.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 1.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 3.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 1.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 1.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 5.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 1.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.0 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.0 | 0.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 0.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.0 | 0.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.9 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.0 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 8.1 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.0 | 0.7 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.4 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.0 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 1.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 2.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 2.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.6 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.0 | 6.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.0 | 0.8 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.0 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 1.2 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.5 | GO:0098793 | presynapse(GO:0098793) |
| 0.0 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
| 0.0 | 0.2 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 1.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.0 | 2.4 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.0 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 1.0 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 7.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.5 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.0 | 0.6 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.0 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.0 | 6.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.5 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.0 | 7.2 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 4.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 2.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 3.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.1 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 8.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.0 | 2.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 1.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 2.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.0 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 2.2 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
| 0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.0 | 0.1 | GO:0030681 | multimeric ribonuclease P complex(GO:0030681) |
| 0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.6 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.2 | GO:0036038 | MKS complex(GO:0036038) |
| 0.0 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.0 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.0 | 1.8 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.0 | 3.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 1.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 0.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 1.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 3.1 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 1.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 0.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.0 | 1.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.1 | GO:0030677 | ribonuclease P complex(GO:0030677) mitochondrial ribonuclease P complex(GO:0030678) |
| 0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 4.3 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.4 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.0 | 0.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 1.7 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 1.4 | 16.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.0 | 12.0 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 1.0 | 2.9 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 1.0 | 3.9 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.9 | 4.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.9 | 6.0 | GO:0016160 | amylase activity(GO:0016160) |
| 0.8 | 4.9 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.7 | 2.2 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.7 | 2.8 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.7 | 2.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.7 | 4.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.7 | 2.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.7 | 3.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.7 | 2.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.7 | 2.0 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
| 0.7 | 3.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.6 | 4.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.6 | 3.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.6 | 4.2 | GO:0042806 | fucose binding(GO:0042806) |
| 0.6 | 4.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.6 | 1.8 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.6 | 2.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.5 | 2.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.5 | 3.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.5 | 3.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.5 | 2.0 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.5 | 4.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.5 | 0.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.4 | 1.8 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.4 | 4.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.4 | 1.8 | GO:0015197 | peptide transporter activity(GO:0015197) peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) peptide transmembrane transporter activity(GO:1904680) |
| 0.4 | 3.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.4 | 3.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.4 | 1.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.4 | 3.3 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.4 | 2.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.4 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.4 | 1.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.4 | 1.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.4 | 3.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.4 | 1.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.4 | 1.5 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.4 | 2.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.3 | 2.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.3 | 1.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.3 | 2.2 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.3 | 3.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 2.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.3 | 1.5 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.3 | 0.9 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.3 | 10.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.3 | 1.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 2.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.3 | 0.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.3 | 2.0 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.3 | 6.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.3 | 1.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.3 | 4.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.3 | 4.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.3 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.3 | 1.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.2 | 1.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.2 | 1.2 | GO:0002046 | opsin binding(GO:0002046) |
| 0.2 | 2.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.2 | 0.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.2 | 1.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.2 | 2.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.2 | 3.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 0.7 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.2 | 4.0 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 2.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 0.9 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.2 | 3.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 16.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 3.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.2 | 0.6 | GO:0004827 | glutamate-tRNA ligase activity(GO:0004818) proline-tRNA ligase activity(GO:0004827) |
| 0.2 | 2.0 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.2 | 1.0 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 0.2 | 3.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 3.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.2 | 2.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.2 | 2.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.2 | 1.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 0.9 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 0.2 | 0.7 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.2 | 1.8 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 4.7 | GO:0055103 | ligase regulator activity(GO:0055103) |
| 0.2 | 0.5 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.2 | 1.6 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.2 | 2.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.2 | 0.5 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.2 | 1.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 4.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 1.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.2 | 0.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.2 | 1.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.2 | 1.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.2 | 0.5 | GO:0030395 | lactose binding(GO:0030395) |
| 0.2 | 0.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 1.3 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 1.6 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 0.7 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.1 | 2.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 0.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.1 | 1.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.1 | 1.4 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.1 | 0.3 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.1 | 0.4 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.1 | 1.4 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.1 | 3.1 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.1 | 0.5 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 7.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 1.8 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
| 0.1 | 0.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.1 | 2.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.8 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 2.1 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 0.4 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.1 | 1.8 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 0.9 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.1 | 0.4 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.1 | 1.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 4.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.1 | 1.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.7 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.1 | 1.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 1.9 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.1 | 6.8 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 6.0 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 3.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.3 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.1 | 0.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.1 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 0.4 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.1 | 0.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.1 | 4.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.1 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 1.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 2.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.3 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.1 | 3.6 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 1.0 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.1 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 0.6 | GO:0070905 | serine binding(GO:0070905) |
| 0.1 | 6.8 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.1 | 0.6 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.1 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.1 | 1.6 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.1 | 2.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.1 | 10.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.1 | 2.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 0.9 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
| 0.1 | 0.3 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.6 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.1 | 0.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 1.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 7.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 1.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.1 | 4.9 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 1.9 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.1 | 1.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.1 | 1.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 2.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.1 | 1.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.3 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 0.2 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.1 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 3.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.1 | 4.3 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 0.4 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.1 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 1.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 2.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 0.5 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
| 0.1 | 0.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.4 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 0.1 | 1.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.1 | 0.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.1 | 1.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 1.1 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.8 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 1.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.1 | 0.7 | GO:0008047 | enzyme activator activity(GO:0008047) |
| 0.1 | 3.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 2.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 3.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 1.9 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 4.4 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.1 | 1.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 2.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 3.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 11.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 2.5 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.1 | 1.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.3 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.1 | 0.5 | GO:0004518 | nuclease activity(GO:0004518) |
| 0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.4 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.1 | 0.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 1.4 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 2.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.1 | 0.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 0.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.0 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.0 | 3.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.0 | 1.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.0 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.0 | 0.9 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.0 | 3.8 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.0 | 0.2 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.0 | 0.6 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.0 | 0.9 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 0.2 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.0 | 6.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.0 | 1.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 1.5 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
| 0.0 | 2.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 1.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.1 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.0 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 0.2 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.0 | 2.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 3.3 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.5 | GO:0004955 | prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.0 | 1.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.6 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.0 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.0 | 0.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.0 | 1.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.0 | 0.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 1.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 5.9 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
| 0.0 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.0 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.0 | 2.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.0 | 0.4 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.0 | 1.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.0 | 0.7 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.0 | 0.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.2 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.0 | 0.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.0 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.0 | 2.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.0 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.0 | 3.2 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.0 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 3.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 5.4 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 2.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.0 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.0 | 16.8 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.0 | 17.0 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.0 | 0.1 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.0 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.0 | 1.0 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.0 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 1.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.0 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
| 0.0 | 13.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.0 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.0 | 0.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.0 | 1.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 0.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 1.0 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 1.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.0 | 0.3 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
| 0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.0 | 0.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.0 | 3.1 | GO:0003823 | antigen binding(GO:0003823) |
| 0.0 | 1.0 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.0 | 0.0 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.0 | 0.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.0 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 0.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 0.9 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.0 | 2.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 7.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.2 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 0.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 2.7 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 0.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.0 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.1 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 22.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 12.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 12.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.2 | 10.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 2.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 2.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 5.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.2 | 4.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 8.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 1.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.1 | 4.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 13.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 4.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 8.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 3.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 7.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 4.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 2.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 3.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 3.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 1.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 6.5 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 3.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 11.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 2.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 0.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.1 | 1.9 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 2.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 4.0 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 1.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 2.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 2.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 1.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 3.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 7.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 2.5 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 1.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 1.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 1.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 2.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 0.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.0 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 3.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 1.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 1.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 1.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 3.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 1.7 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 1.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 2.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 1.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 1.2 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 1.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 17.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.5 | 2.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.4 | 6.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.3 | 6.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.3 | 3.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.3 | 8.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 4.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.2 | 4.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 5.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 4.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 14.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 3.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.2 | 3.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.2 | 2.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.2 | 11.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 2.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 4.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 1.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 2.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 16.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 3.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 4.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 10.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 6.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 5.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 2.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 5.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 4.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 2.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 3.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 3.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 3.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 4.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 4.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 3.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 0.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.1 | 5.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.1 | 1.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 2.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 1.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.1 | 11.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 2.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 2.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.1 | 3.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 2.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 0.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 4.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 1.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 1.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.1 | 5.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 0.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 0.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
| 0.1 | 1.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 5.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 2.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 1.9 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.1 | 1.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 3.3 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 2.8 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.0 | 0.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.0 | 4.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 7.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 2.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 1.1 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 1.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 5.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 2.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 2.8 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.0 | 0.2 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 1.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 0.9 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 0.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 1.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.5 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
| 0.0 | 1.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 2.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 2.6 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 4.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 0.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.0 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 1.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 0.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.0 | 0.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.0 | 2.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |